What are the brand names for the DPP‑4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin, and teneligliptin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

DPP-4 Inhibitor Brand Names

The brand names for these DPP-4 inhibitors are:

  • Alogliptin: Vipidia 1, 2
  • Linagliptin: Trajenta 2
  • Saxagliptin: Onglyza 3, 2
  • Sitagliptin: Not explicitly listed in the provided evidence, but widely marketed as Januvia
  • Vildagliptin: Not explicitly listed in the provided evidence, but widely marketed as Galvus
  • Teneligliptin: Not listed in the provided evidence

Note: The FDA drug labels confirm saxagliptin is marketed as Onglyza 3 and alogliptin formulations are available under the brand name Vipidia 2. Sitagliptin and vildagliptin brand names are based on general medical knowledge as they were not specified in the provided evidence documents. Teneligliptin brand name information was not available in the evidence provided.

References

2
Research

An update on the 'gliptins'.

Drug and therapeutics bulletin, 2016

Related Questions

How should hypoglycemia caused by a DPP‑4 inhibitor (e.g., sitagliptin, saxagliptin, linagliptin, alogliptin) be evaluated and managed?
In an adult with type 2 diabetes whose glycemic control is inadequate on metformin alone, what DPP‑4 inhibitors can be added, and what are their dosing regimens, contraindications, and monitoring considerations?
Is saxagliptin the DPP‑4 inhibitor most likely to cause muscle or joint pain?
What are the effects of Dipeptidyl Peptidase-4 (DPP-4) inhibitors?
In an adult with type 2 diabetes whose glucose remains above target despite metformin, how should DPP‑4 inhibitors be selected and dosed considering renal function and heart‑failure status?
Which type of viruses are more stable on microplastic surfaces?
What is the recommended management for tooth pain in a patient awaiting endodontic treatment (TPR) without signs of infection?
What role do biofilms on microplastics play in viral dynamics?
Which arboviral infection is the most concerning for a traveler to Brazil: chikungunya, yellow fever, or Zika?
What are the clinical findings associated with yellow fever, chikungunya infection, and Zika virus infection?
In a patient with alcohol‑induced cirrhosis, should the diagnosis be alcohol abuse or alcohol dependence?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.